Newton Charles W. 4
4 · Lyell Immunopharma, Inc. · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Newton Charles W.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-03-17$0.56/sh+200,000$111,620→ 200,000 total(indirect: By Trust)
Holdings
- 172,725
Common Stock
Footnotes (2)
- [F1]The price reported above reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $0.54 to $0.56, inclusive. Upon request from the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this range
- [F2]Shares held by The Charles & Lisa Newton Living Trust. The Reporting Person is co-trustee and co-grantor of The Charles & Lisa Newton Living Trust.